[Federal Register Volume 63, Number 221 (Tuesday, November 17, 1998)]
[Notices]
[Pages 63946-63947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-30631]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 30, 1998, and published in the Federal
Register on July 9, 1998, (63 FR 37139), Research Biochemicals, Inc.,
which has changed its name to Sigma Aldrich Research Biochemicals,
Inc., One Three Strathmore Road, Attn: Richard A. Milius, PhD, Natick,
Massachusetts 01760, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)............................................ I
Methcathinone (1237)........................................ I
4-Bromo-2, 5-dimethoxyamphetamine (7391).................... I
4-Bromo-2, 5-dimethoxyphenethylamine (7392)................. I
2, 5-Dimethoxyamphetamine (7396)............................ I
3, 4-Methylenedioxyamphetamine (7400)....................... I
N-Hydroxy-3, 4-methylenedioxyamphetamine (7402)............. I
3, 4-Methylenedioxy-N-ethylamphetamine (7404)............... I
3, 4-Methylenedioxymethamphetamine (7405)................... I
1-[1-(2-Thienyl) cyclohexyl]piperidine (7470)............... I
Heroin (9200)............................................... I
Amphetamine (1100).......................................... II
Phencyclidine (7471)........................................ II
Benzoylecgonine (9180)...................................... II
------------------------------------------------------------------------
The firm plans to manufacture the listed controlled substances for
laboratory reference standards and neurochemicals.
DEA has considered the factors in Title 21, United States Code,
Section 823(a) and determined that the registration of Research
Biochemicals, Inc. to manufacture the listed controlled
[[Page 63947]]
substances is consistent with the public interest at this time. DEA has
investigated Research Biochemicals, Inc. on a regular basis to ensure
that the company's continued registration is consistent with the public
interest. These investigations have included inspection and testing of
the company's physical security systems, audits of the company's
records, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy
Assistant Administrator, Office of Diversion Control, hereby orders
that the application submitted by the above firm for registration as a
bulk manufacturer of the basic classes of controlled substances listed
above is granted.
Dated: October 19, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 98-30631 Filed 11-16-98; 8:45 am]
BILLING CODE 4410-09-M
